Meto vs. Dr B: Which Metabolic Health Platform is Right for You?

Dr B is a telehealth platform that began by helping people access leftover COVID-19 vaccines, but has since evolved into a low-cost online prescribing service for treatments like GLP-1 medications, acne care, cold sores, and more. Its primary appeal lies in affordability and speed — users can fill out an online intake form, get reviewed by a licensed provider, and receive prescriptions for various medications, often without needing a video visit. In the context of weight loss, Dr. B offers access to prescription GLP-1s such as semaglutide and tirzepatide for eligible patients, making it a go-to option for those looking to obtain medications quickly and discreetly.

Meto, by contrast, is a doctor-led metabolic health platform that goes beyond fast access to prescriptions. Rather than offering medications in isolation, Meto delivers holistic, medically supervised care to address the root causes of weight gain and metabolic dysfunction. Patients are guided through a structured journey that includes lab work, AI-enhanced monitoring, personalized nutrition and movement plans, and access to providers trained in metabolic, hormonal, and longevity health. While Meto also offers GLP-1 prescriptions when clinically appropriate, the focus is on restoring metabolic function and delivering long-term results — not just filling prescriptions.

Features	Meto	Dr B
Approach to Care	Medical-led, personalized metabolic and hormonal health care.	Medication-first model with minimal care customization.
Use of Technology	AI-powered insights, lab & device integration, remote monitoring.	Digital intake forms and asynchronous provider review.
Insurance Coverage	Accepts most major insurance providers.	Cash pay only; does not accept insurance.
Pricing Model	Copay-based or membership; transparent and insurance-compatible.	Flat-fee per consultation; prescription costs vary.
Clinical Team Availability	Access to licensed physicians, metabolic health specialists, dietitians, and coaches.	Licensed clinicians available via asynchronous review; no care team continuity.
Availability	U.S.-focused with multi-state provider network.	Available in most U.S. states; online only.
Program Flexibility	Ongoing plan adjustments based on labs and outcomes.	No care plan structure; medication-only access.
Patient Support	Dedicated care team for continuous, one-on-one support.	Limited follow-up; patient support primarily tech-related.
Mobile & Web Experience	Robust platform with clinical dashboard and tracking tools.	Streamlined web-based intake and messaging.
Community and Peer Support	Growing provider-led community with group support options.	No community or coaching features.

Dr. B is designed for convenience and access. The platform aims to simplify and reduce the cost of obtaining medications like GLP-1s by removing traditional healthcare barriers. This model appeals to users who may not want in-person or virtual consultations and instead prefer fast, affordable access to prescriptions. While this approach helps democratize access, it is not structured to provide in-depth care or long-term metabolic support. Its primary focus is transactional — connecting users to medications, not guiding them through a full health journey.

Meto, on the other hand, operates from a systems-level view of metabolic health. It recognizes that weight challenges often stem from complex biological, hormonal, and behavioral factors. Meto’s care model is designed to uncover those root issues through lab testing, provider consults, and AI monitoring. It’s not just about prescribing — it’s about rebalancing your body’s systems, improving longevity, and building sustainable health practices over time. While both platforms may offer access to the same medications, Meto’s philosophy is rooted in clinical depth and long-term outcomes, not just access.

Dr B connects users with licensed healthcare professionals, but the process is entirely asynchronous — patients fill out a form, and a provider approves the prescription behind the scenes. There is typically no real-time interaction unless required. Ongoing clinical care is not included, and communication tends to be minimal. While the providers are qualified, their role is largely administrative and focused on prescription eligibility rather than integrated patient care.

Meto delivers medical weight care as a continuous service. Providers are involved from the beginning and remain engaged throughout the patient’s journey. From diagnostics to medication titration to ongoing behavior support, the care is proactive and tailored. Patients interact with a multidisciplinary team that includes physicians, nutritionists, and coaches, all of whom are aligned around the goal of improving metabolic health. The experience is personal, coordinated, and designed to evolve with the patient’s needs — not just rubber-stamp a prescription.

Dr. B’s approach to personalization is minimal. The platform screens for basic eligibility criteria like BMI and medical history, and if a patient qualifies, they are offered access to GLP-1 prescriptions. There are no lab tests, clinical assessments, or comprehensive health evaluations. Once a medication is prescribed, the patient is responsible for self-managing their journey with limited interaction or follow-up care.

In contrast, Meto centers personalization as the foundation of its care model. Every patient undergoes detailed onboarding, including labs, symptom tracking, and metabolic assessments. Care plans are then crafted by licensed providers based on unique hormonal and physiological profiles. These plans are dynamic — adjusted regularly using real-time data from wearables, feedback loops, and AI-powered alerts. Whether someone is struggling with insulin resistance, PCOS, or perimenopausal weight gain, Meto designs around the root cause and adapts the plan as the patient progresses.

Dr. B makes GLP-1 access simple and affordable. With a quick intake and no live consultation, eligible patients can get prescriptions for medications like Ozempic or Wegovy. However, this process is largely unaccompanied — patients must source their medication, manage side effects, and handle questions without structured medical guidance. There’s no deprescribing strategy or integrated support beyond the initial approval.

Meto treats medication as one part of a much broader clinical strategy. GLP-1s are prescribed only when appropriate and as part of a holistic, ongoing care plan. Patients are monitored continuously for effectiveness, side effects, and dosage needs, with nutrition and behavior coaching layered in. Importantly, Meto supports deprescribing — helping patients eventually taper off medications as metabolic health is restored. This thoughtful, full-spectrum approach ensures medications work with the patient’s biology and care team, not in isolation.

Dr B is best for individuals looking for fast, low-cost access to medications — particularly GLP-1s — with minimal friction. It may suit people who are already informed about these drugs and don’t need or want a broader care plan. The simplicity of Dr. B’s offering makes it attractive to those who are cost-conscious and confident managing their weight journey solo, without ongoing provider engagement.

Meto is built for those who want more than a prescription. If you're dealing with stubborn weight gain, hormonal imbalances, or chronic metabolic issues, and you want a medical team to guide you every step of the way — Meto is for you. It’s ideal for people who want to stop guessing and start getting clinical clarity about their bodies. With comprehensive diagnostics, continuous support, and true personalization, Meto provides a long-term, expert-driven path to lasting weight and metabolic health.